Skip to content

Clinical trials

Glioblastoma trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioblastoma Country / region: Taiwan Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20082
20111
20121
20131
20141
20153
20162
20173
20182
20192
20204
20213
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status7
Recruiting3
Terminated3
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NaviFUS Corporation4
AbbVie2
Novartis Pharmaceuticals2
Taichung Veterans General Hospital2
Apollomics Inc.1
Bayer1
CANbridge Life Sciences Ltd.1
Celldex Therapeutics1
China Medical University Hospital1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioblastoma29
Glioma12
Brain Neoplasms11
Neoplasms7
Astrocytoma5
Neoplasms, Nerve Tissue3
Stomach Neoplasms3
Breast Neoplasms2
Carcinoma, Non-Small-Cell Lung2
Cholangiocarcinoma2

Trials

Showing 26 to 29 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.